Evoke Pharma, Inc. (EVOK)
11.00
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
Evoke Pharma Total Liabilities (Quarterly) : 12.29M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 12.29M |
| June 30, 2025 | 11.69M |
| March 31, 2025 | 10.53M |
| December 31, 2024 | 10.48M |
| September 30, 2024 | 9.766M |
| June 30, 2024 | 9.471M |
| March 31, 2024 | 8.957M |
| December 31, 2023 | 9.648M |
| September 30, 2023 | 8.727M |
| June 30, 2023 | 8.441M |
| March 31, 2023 | 7.913M |
| December 31, 2022 | 7.767M |
| September 30, 2022 | 7.878M |
| June 30, 2022 | 7.213M |
| March 31, 2022 | 7.092M |
| December 31, 2021 | 7.018M |
| September 30, 2021 | 6.877M |
| June 30, 2021 | 11.59M |
| March 31, 2021 | 11.48M |
| December 31, 2020 | 12.65M |
| September 30, 2020 | 8.674M |
| June 30, 2020 | 8.641M |
| March 31, 2020 | 1.716M |
| December 31, 2019 | 2.015M |
| September 30, 2019 | 2.154M |
| Date | Value |
|---|---|
| June 30, 2019 | 1.285M |
| March 31, 2019 | 1.287M |
| December 31, 2018 | 1.634M |
| September 30, 2018 | 1.611M |
| June 30, 2018 | 1.266M |
| March 31, 2018 | 1.196M |
| December 31, 2017 | 5.776M |
| September 30, 2017 | 8.700M |
| June 30, 2017 | 6.386M |
| March 31, 2017 | 6.904M |
| December 31, 2016 | 5.507M |
| September 30, 2016 | 6.11M |
| June 30, 2016 | 6.163M |
| March 31, 2016 | 6.115M |
| December 31, 2015 | 6.068M |
| September 30, 2015 | 6.375M |
| June 30, 2015 | 6.296M |
| March 31, 2015 | 6.188M |
| December 31, 2014 | 6.113M |
| September 30, 2014 | 1.700M |
| June 30, 2014 | 1.854M |
| March 31, 2014 | 4.116M |
| December 31, 2013 | 3.803M |
| September 30, 2013 | 4.515M |
| June 30, 2013 | 3.729M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 115.90B |
| Eli Lilly & Co. | 108.40B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.65M |
| Shareholders Equity (Quarterly) | 3.362M |